Global Oral Antidiabetic Agents Market Size, Status and Forecast 2019-2025
SKU ID :QYR-13887838 | Published Date: 15-Apr-2019 | No. of pages: 94Description
TOC
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Oral Antidiabetic Agents Market Size Growth Rate by Type (2014-2025)
1.4.2 Sulfonylureas
1.4.3 Meglitinides
1.4.4 Biguanides
1.4.5 Thiazolidinediones
1.4.6 Alpha-glucosidase Inhibitors
1.5 Market by Application
1.5.1 Global Oral Antidiabetic Agents Market Share by Application (2014-2025)
1.5.2 Home Use
1.5.3 Medical Institutions
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Oral Antidiabetic Agents Market Size
2.2 Oral Antidiabetic Agents Growth Trends by Regions
2.2.1 Oral Antidiabetic Agents Market Size by Regions (2014-2025)
2.2.2 Oral Antidiabetic Agents Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Oral Antidiabetic Agents Market Size by Manufacturers
3.1.1 Global Oral Antidiabetic Agents Revenue by Manufacturers (2014-2019)
3.1.2 Global Oral Antidiabetic Agents Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Oral Antidiabetic Agents Market Concentration Ratio (CR5 and HHI)
3.2 Oral Antidiabetic Agents Key Players Head office and Area Served
3.3 Key Players Oral Antidiabetic Agents Product/Solution/Service
3.4 Date of Enter into Oral Antidiabetic Agents Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Oral Antidiabetic Agents Market Size by Type (2014-2019)
4.2 Global Oral Antidiabetic Agents Market Size by Application (2014-2019)
5 United States
5.1 United States Oral Antidiabetic Agents Market Size (2014-2019)
5.2 Oral Antidiabetic Agents Key Players in United States
5.3 United States Oral Antidiabetic Agents Market Size by Type
5.4 United States Oral Antidiabetic Agents Market Size by Application
6 Europe
6.1 Europe Oral Antidiabetic Agents Market Size (2014-2019)
6.2 Oral Antidiabetic Agents Key Players in Europe
6.3 Europe Oral Antidiabetic Agents Market Size by Type
6.4 Europe Oral Antidiabetic Agents Market Size by Application
7 China
7.1 China Oral Antidiabetic Agents Market Size (2014-2019)
7.2 Oral Antidiabetic Agents Key Players in China
7.3 China Oral Antidiabetic Agents Market Size by Type
7.4 China Oral Antidiabetic Agents Market Size by Application
8 Japan
8.1 Japan Oral Antidiabetic Agents Market Size (2014-2019)
8.2 Oral Antidiabetic Agents Key Players in Japan
8.3 Japan Oral Antidiabetic Agents Market Size by Type
8.4 Japan Oral Antidiabetic Agents Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Oral Antidiabetic Agents Market Size (2014-2019)
9.2 Oral Antidiabetic Agents Key Players in Southeast Asia
9.3 Southeast Asia Oral Antidiabetic Agents Market Size by Type
9.4 Southeast Asia Oral Antidiabetic Agents Market Size by Application
10 India
10.1 India Oral Antidiabetic Agents Market Size (2014-2019)
10.2 Oral Antidiabetic Agents Key Players in India
10.3 India Oral Antidiabetic Agents Market Size by Type
10.4 India Oral Antidiabetic Agents Market Size by Application
11 Central & South America
11.1 Central & South America Oral Antidiabetic Agents Market Size (2014-2019)
11.2 Oral Antidiabetic Agents Key Players in Central & South America
11.3 Central & South America Oral Antidiabetic Agents Market Size by Type
11.4 Central & South America Oral Antidiabetic Agents Market Size by Application
12 International Players Profiles
12.1 Novo Nordisk
12.1.1 Novo Nordisk Company Details
12.1.2 Company Description and Business Overview
12.1.3 Oral Antidiabetic Agents Introduction
12.1.4 Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2014-2019)
12.1.5 Novo Nordisk Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Oral Antidiabetic Agents Introduction
12.2.4 Eli Lilly Revenue in Oral Antidiabetic Agents Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Oral Antidiabetic Agents Introduction
12.3.4 Sanofi Revenue in Oral Antidiabetic Agents Business (2014-2019)
12.3.5 Sanofi Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Oral Antidiabetic Agents Introduction
12.4.4 Roche Revenue in Oral Antidiabetic Agents Business (2014-2019)
12.4.5 Roche Recent Development
12.5 Teva
12.5.1 Teva Company Details
12.5.2 Company Description and Business Overview
12.5.3 Oral Antidiabetic Agents Introduction
12.5.4 Teva Revenue in Oral Antidiabetic Agents Business (2014-2019)
12.5.5 Teva Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Company Details
12.6.2 Company Description and Business Overview
12.6.3 Oral Antidiabetic Agents Introduction
12.6.4 AstraZeneca Revenue in Oral Antidiabetic Agents Business (2014-2019)
12.6.5 AstraZeneca Recent Development
12.7 Wockhardt UK
12.7.1 Wockhardt UK Company Details
12.7.2 Company Description and Business Overview
12.7.3 Oral Antidiabetic Agents Introduction
12.7.4 Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2014-2019)
12.7.5 Wockhardt UK Recent Development
12.8 Merck
12.8.1 Merck Company Details
12.8.2 Company Description and Business Overview
12.8.3 Oral Antidiabetic Agents Introduction
12.8.4 Merck Revenue in Oral Antidiabetic Agents Business (2014-2019)
12.8.5 Merck Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Oral Antidiabetic Agents Introduction
12.9.4 Pfizer Revenue in Oral Antidiabetic Agents Business (2014-2019)
12.9.5 Pfizer Recent Development
12.10 Cipla
12.10.1 Cipla Company Details
12.10.2 Company Description and Business Overview
12.10.3 Oral Antidiabetic Agents Introduction
12.10.4 Cipla Revenue in Oral Antidiabetic Agents Business (2014-2019)
12.10.5 Cipla Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Tables & Figures
List of Tables and Figures
Table Oral Antidiabetic Agents Key Market Segments
Table Key Players Oral Antidiabetic Agents Covered
Table Global Oral Antidiabetic Agents Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Oral Antidiabetic Agents Market Size Market Share by Type 2014-2025
Figure Sulfonylureas Figures
Table Key Players of Sulfonylureas
Figure Meglitinides Figures
Table Key Players of Meglitinides
Figure Biguanides Figures
Table Key Players of Biguanides
Figure Thiazolidinediones Figures
Table Key Players of Thiazolidinediones
Figure Alpha-glucosidase Inhibitors Figures
Table Key Players of Alpha-glucosidase Inhibitors
Table Global Oral Antidiabetic Agents Market Size Growth by Application 2014-2025 (Million US$)
Figure Home Use Case Studies
Figure Medical Institutions Case Studies
Figure Others Case Studies
Figure Oral Antidiabetic Agents Report Years Considered
Table Global Oral Antidiabetic Agents Market Size 2014-2025 (Million US$)
Figure Global Oral Antidiabetic Agents Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Oral Antidiabetic Agents Market Size by Regions 2014-2025 (Million US$)
Table Global Oral Antidiabetic Agents Market Size by Regions 2014-2019 (Million US$)
Table Global Oral Antidiabetic Agents Market Share by Regions 2014-2019
Figure Global Oral Antidiabetic Agents Market Share by Regions 2014-2019
Figure Global Oral Antidiabetic Agents Market Share by Regions 2019
Table Market Top Trends
Table Global Oral Antidiabetic Agents Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Oral Antidiabetic Agents Market Share by Manufacturers (2014-2019)
Figure Global Oral Antidiabetic Agents Market Share by Manufacturers in 2018
Table Global Oral Antidiabetic Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Oral Antidiabetic Agents Product/Solution/Service
Table Date of Enter into Oral Antidiabetic Agents Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Oral Antidiabetic Agents Market Size by Type (2014-2019) (Million US$)
Table Global Oral Antidiabetic Agents Market Size Share by Type (2014-2019)
Figure Global Oral Antidiabetic Agents Market Size Market Share by Type (2014-2019)
Table Global Oral Antidiabetic Agents Market Size by Application (2014-2019) (Million US$)
Table Global Oral Antidiabetic Agents Market Size Share by Application (2014-2019)
Figure Global Oral Antidiabetic Agents Market Size Market Share by Application (2014-2019)
Figure Global Oral Antidiabetic Agents Revenue Market Share by Application in 2018
Figure United States Oral Antidiabetic Agents Market Size 2014-2019 (Million US$)
Table United States Key Players Oral Antidiabetic Agents Revenue (2018-2019) (Million US$)
Table United States Key Players Oral Antidiabetic Agents Market Share (2018-2019)
Table United States Oral Antidiabetic Agents Market Size by Type (2014-2019) (Million US$)
Table United States Oral Antidiabetic Agents Market Share by Type (2014-2019)
Table United States Oral Antidiabetic Agents Market Size by Application (2014-2019) (Million US$)
Table United States Oral Antidiabetic Agents Market Share by Application (2014-2019)
Figure Europe Oral Antidiabetic Agents Market Size 2014-2019 (Million US$)
Table Europe Key Players Oral Antidiabetic Agents Revenue (2018-2019) (Million US$)
Table Europe Key Players Oral Antidiabetic Agents Market Share (2018-2019)
Table Europe Oral Antidiabetic Agents Market Size by Type (2014-2019) (Million US$)
Table Europe Oral Antidiabetic Agents Market Share by Type (2014-2019)
Table Europe Oral Antidiabetic Agents Market Size by Application (2014-2019) (Million US$)
Table Europe Oral Antidiabetic Agents Market Share by Application (2014-2019)
Figure China Oral Antidiabetic Agents Market Size 2014-2019 (Million US$)
Table China Key Players Oral Antidiabetic Agents Revenue (2018-2019) (Million US$)
Table China Key Players Oral Antidiabetic Agents Market Share (2018-2019)
Table China Oral Antidiabetic Agents Market Size by Type (2014-20189) (Million US$)
Table China Oral Antidiabetic Agents Market Share by Type (2014-2019)
Table China Oral Antidiabetic Agents Market Size by Application (2014-2019) (Million US$)
Table China Oral Antidiabetic Agents Market Share by Application (2014-2019)
Figure Japan Oral Antidiabetic Agents Market Size 2014-2019 (Million US$)
Table Japan Key Players Oral Antidiabetic Agents Revenue (2018-2019) (Million US$)
Table Japan Key Players Oral Antidiabetic Agents Market Share (2018-2019)
Table Japan Oral Antidiabetic Agents Market Size by Type (2014-2019) (Million US$)
Table Japan Oral Antidiabetic Agents Market Share by Type (2014-2019)
Table Japan Oral Antidiabetic Agents Market Size by Application (2014-2019) (Million US$)
Table Japan Oral Antidiabetic Agents Market Share by Application (2014-2019)
Figure Southeast Asia Oral Antidiabetic Agents Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Oral Antidiabetic Agents Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Oral Antidiabetic Agents Market Share (2018-2019)
Table Southeast Asia Oral Antidiabetic Agents Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Oral Antidiabetic Agents Market Share by Type (2014-2019)
Table Southeast Asia Oral Antidiabetic Agents Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Oral Antidiabetic Agents Market Share by Application (2014-2019)
Figure India Oral Antidiabetic Agents Market Size 2014-2019 (Million US$)
Table India Key Players Oral Antidiabetic Agents Revenue (2018-2019) (Million US$)
Table India Key Players Oral Antidiabetic Agents Market Share (2018-2019)
Table India Oral Antidiabetic Agents Market Size by Type (2014-2019) (Million US$)
Table India Oral Antidiabetic Agents Market Share by Type (2014-2019)
Table India Oral Antidiabetic Agents Market Size by Application (2014-2019) (Million US$)
Table India Oral Antidiabetic Agents Market Share by Application (2014-2019)
Figure Central & South America Oral Antidiabetic Agents Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Oral Antidiabetic Agents Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Oral Antidiabetic Agents Market Share (2018-2019)
Table Central & South America Oral Antidiabetic Agents Market Size by Type (2014-2019) (Million US$)
Table Central & South America Oral Antidiabetic Agents Market Share by Type (2014-2019)
Table Central & South America Oral Antidiabetic Agents Market Size by Application (2014-2019) (Million US$)
Table Central & South America Oral Antidiabetic Agents Market Share by Application (2014-2019)
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2014-2019) (Million US$)
Figure Novo Nordisk Revenue Growth Rate in Oral Antidiabetic Agents Business (2014-2019)
Table Novo Nordisk Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Oral Antidiabetic Agents Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Oral Antidiabetic Agents Business (2014-2019)
Table Eli Lilly Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Oral Antidiabetic Agents Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Oral Antidiabetic Agents Business (2014-2019)
Table Sanofi Recent Development
Table Roche Company Details
Table Roche Revenue in Oral Antidiabetic Agents Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Oral Antidiabetic Agents Business (2014-2019)
Table Roche Recent Development
Table Teva Company Details
Table Teva Revenue in Oral Antidiabetic Agents Business (2014-2019)(Million US$)
Figure Teva Revenue Growth Rate in Oral Antidiabetic Agents Business (2014-2019)
Table Teva Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Oral Antidiabetic Agents Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Oral Antidiabetic Agents Business (2014-2019)
Table AstraZeneca Recent Development
Table Wockhardt UK Company Details
Table Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2014-2019)(Million US$)
Figure Wockhardt UK Revenue Growth Rate in Oral Antidiabetic Agents Business (2014-2019)
Table Wockhardt UK Recent Development
Table Merck Company Details
Table Merck Revenue in Oral Antidiabetic Agents Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Oral Antidiabetic Agents Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Oral Antidiabetic Agents Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Oral Antidiabetic Agents Business (2014-2019)
Table Pfizer Recent Development
Table Cipla Company Details
Table Cipla Revenue in Oral Antidiabetic Agents Business (2014-2019)(Million US$)
Figure Cipla Revenue Growth Rate in Oral Antidiabetic Agents Business (2014-2019)
Table Cipla Recent Development
Table Global Oral Antidiabetic Agents Market Size by Regions (Million US$) 2019-2025
Figure Global Oral Antidiabetic Agents Market Size Share by Regions (2019-2025)
Figure Global Oral Antidiabetic Agents Market Size Share by Regions in 2025
Figure United States Oral Antidiabetic Agents Market Size Forecast (2019-2025)(Million USD)
Figure Europe Oral Antidiabetic Agents Market Size Forecast (2019-2025)(Million USD)
Figure China Oral Antidiabetic Agents Market Size Forecast (2019-2025)(Million USD)
Figure Japan Oral Antidiabetic Agents Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Oral Antidiabetic Agents Market Size Forecast (2019-2025)(Million USD)
Figure India Oral Antidiabetic Agents Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Oral Antidiabetic Agents Market Size Forecast (2019-2025)(Million USD)
Table Global Oral Antidiabetic Agents Market Size by Product (2019-2025) (Million US$)
Figure Global Oral Antidiabetic Agents Market Size by Product (2019-2025)
Figure Global Oral Antidiabetic Agents Market Size by Product in 2025
Table Global Oral Antidiabetic Agents Market Size by Application (2019-2025) (Million US$)
Figure Global Oral Antidiabetic Agents Market Size by Application (2019-2025)
Figure Global Oral Antidiabetic Agents Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Companies
Novo Nordisk
Eli Lilly
Sanofi
Roche
Teva
AstraZeneca
Wockhardt UK
Merck
Pfizer
Cipla
- PRICE
-
$3900$7800